Edmond de Rothschild Holding’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-50,000
| Closed | -$51K | – | 629 |
|
|
2024
Q2 | $51K | Hold |
50,000
| – | – | ﹤0.01% | 556 |
|
|
2024
Q1 | $91.5K | Hold |
50,000
| – | – | ﹤0.01% | 512 |
|
|
2023
Q4 | $62K | Hold |
50,000
| – | – | ﹤0.01% | 548 |
|
|
2023
Q3 | $57K | Hold |
50,000
| – | – | ﹤0.01% | 550 |
|
|
2023
Q2 | $45.8K | Hold |
50,000
| – | – | ﹤0.01% | 579 |
|
|
2023
Q1 | $28K | Hold |
50,000
| – | – | ﹤0.01% | 642 |
|
|
2022
Q4 | $28.9K | Hold |
50,000
| – | – | ﹤0.01% | 689 |
|
|
2022
Q3 | $16K | Hold |
50,000
| – | – | ﹤0.01% | 746 |
|
|
2022
Q2 | $18K | Hold |
50,000
| – | – | ﹤0.01% | 733 |
|
|
2022
Q1 | $36K | Hold |
50,000
| – | – | ﹤0.01% | 704 |
|
|
2021
Q4 | $113K | Hold |
50,000
| – | – | ﹤0.01% | 613 |
|
|
2021
Q3 | $144K | Hold |
50,000
| – | – | ﹤0.01% | 581 |
|
|
2021
Q2 | $190K | Hold |
50,000
| – | – | ﹤0.01% | 533 |
|
|
2021
Q1 | $170K | Buy |
+50,000
| New | +$170K | ﹤0.01% | 493 |
|